Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
79.31
-0.28 (-0.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Astrazeneca Plc ADR
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
44
45
Next >
Novavax Looks Primed and Ready for a Vaccine Comeback
November 04, 2021
NVAX stock looks enticing now after falling steeply due to delays in FDA emergency approval as well as other manufacturing issues.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32
November 03, 2021
OCGN stock has moved higher despite little evidence anything’s changed regarding Ocugen’s revenue potential in the U.S.
Via
InvestorPlace
Exposures
COVID-19
PhaseBio's Bentracimab Reverses Ticagrelor-Associated Antiplatelet Activity In Mid-Stage Study
November 03, 2021
PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) has announced topline data from its Phase 2b trial of bentracimab in healthy, older volunteers 50-80 years old. The...
Via
Benzinga
Election Day
November 02, 2021
Teva rose a whopping 8.34% today.
Via
Talk Markets
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
November 01, 2021
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine...
Via
Benzinga
AstraZeneca To Offload Some Drug Rights To Covis Pharma For $270M
November 01, 2021
AstraZeneca Plc (NASDAQ: AZN) will transfer global rights for respiratory medicines Eklira and Duaklir to Covis Pharma Group for $270 million. Covis will also...
Via
Benzinga
Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated
November 01, 2021
Novavax stock offers a unique opportunity to invest in a late stage biotech built on cutting-edge vaccine technology, NVAX stock has surged on its Covid-19 vaccine potential, but don't forget its work...
Via
InvestorPlace
Exposures
COVID-19
Millions Of JNJ COVID-19 Shots Sit Idle At Emergent's Baltimore Plant: Reuters
October 28, 2021
Around 30 million to 50 million doses of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine manufactured earlier this year sit idle in Emergent BioSolutions...
Via
Benzinga
Exposures
COVID-19
Tuesday Market Coverage
October 26, 2021
Thermo Electron fell on the publication of its social responsibility report today.
Via
Talk Markets
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
October 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...
Via
Benzinga
AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial
October 26, 2021
AstraZeneca Plc (NASDAQ: AZN) revealed topline results from the Phase 3 TOPAZ-1 study. Related: AstraZeneca Touts Longest Survival Update In Lung Cancer...
Via
Benzinga
Cyber Currency
October 26, 2021
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.
Via
Talk Markets
Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
October 23, 2021
AstraZeneca's therapy could have at least one major advantage.
Via
The Motley Fool
Exposures
COVID-19
2 COVID Stocks I'd Consider Instead of Moderna
October 21, 2021
Moderna has likely peaked. There are much safer growth stocks to buy right now.
Via
The Motley Fool
Exposures
COVID-19
Wednesday Market Coverage
October 20, 2021
Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.
Via
Talk Markets
AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
October 20, 2021
AstraZeneca Plc (NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential safety issue. Two years ago, the FDA hit ...
Via
Benzinga
Exposures
Product Safety
Novavax Shares Plunge To Lows Since Mid-May As COVID-19 Vaccine Woes Continue
October 20, 2021
Shares of Novavax, Inc. (NASDAQ: NVAX), which is facing an inordinate delay in getting authorization for its COVID-19 vaccine, are moving sharply lower Wednesday....
Via
Benzinga
Exposures
COVID-19
The Secret To Successful Investing In Biotech
October 19, 2021
Have you ever had a stock jump 30%, 50% or 100% in one day?
Via
Talk Markets
AstraZeneca, Unilever Tumble As FTSE 100 Struggles With Rising Energy Prices
October 19, 2021
Shares of COVID-19 vaccine maker AstraZeneca PLC (NASDAQ: AZN) along with other multinational British companies such as Unilever PLC (NYSE: UL), Diageo PLC (NYSE: DEO),...
Via
Benzinga
Exposures
COVID-19
Chinese Growth Level
October 18, 2021
The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues.
Via
Talk Markets
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
October 18, 2021
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...
Via
Talk Markets
Why Are Valneva's Shares Trading Higher Monday Premarket?
October 18, 2021
Valneva SE's (NASDAQ: VALN) COVID-19 vaccine elicits a robust immune response with far fewer side effects than the Oxford/AstraZeneca plc's (NASDAQ: AZN) jab,...
Via
Benzinga
Exposures
COVID-19
Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?
October 16, 2021
Probably not.
Via
The Motley Fool
Exposures
COVID-19
Europe's Unicorns
October 15, 2021
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit.
Via
Talk Markets
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
October 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For...
Via
Benzinga
Exposures
COVID-19
Product Safety
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
October 14, 2021
It may not be a matter of if, but a matter of how high.
Via
The Motley Fool
Biotech Stocks Are Lagging, Is It Time to Rebalance Your Healthcare Portfolio?
October 11, 2021
You may have seen that biotech stocks have been in a funk. The IBB has broken through the SMA-200 support line near $160 and it holds a perilous perch at $155, up only about 2.5% year-to-date. The IBB...
Via
Talk Markets
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
AstraZeneca Plc (NASDAQ: AZN) released top-line data from the TACKLE Phase 3 trial in which its experimental COVID-19 drug has helped cut the risk of severe disease...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Merck Stock Slips Slightly As It Asks FDA To Authorize Covid Pill
October 11, 2021
Merck asked the FDA to authorize its Ridgeback-partnered Covid pill.
Via
Investor's Business Daily
Topics
Death
Exposures
Death
Product Safety
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
44
45
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.